The E6 and E7 proteins of the high risk human papillomaviruses (HPVs) are consistently expressed in HPV-positive cervical carcinomas. We investigated the ability of HPV-16 E6 and E7 to disrupt mitotic checkpoints in normal diploid human cells. Acute expression of HPV-16 E6, but not HPV-16 E7, decreased the ®delity of multiple checkpoints controlling entry into and exit from mitosis. After irradiation, nearly 50% of cells containing HPV-16 E6 readily entered mitosis as opposed to less than 10% of control cells. Consistent with this, asynchronous populations of cells expressing HPV-16 E6 had increased cdc2-associated histone H1 kinase activity relative to control populations. In addition, HPV-16 E6 increased sensitivity to chemically-induced S-phase premature mitosis and decreased mitotic spindle assembly checkpoint function relative to control populations. HPV-16 E6 mutants with a reduced ability to target p53 for degradation were unable to abrogate mitotic checkpoints, suggesting a possible mechanism by which HPV-16 E6 disrupts mitotic checkpoints. Expression of a mutant p53 gene yielded an intermediate phenotype relative to HPV-16 E6, generating moderate increases in sensitivity to chemically-induced S-phase PCC and mitotic spindle disruption and a heightened propensity to enter mitosis after irradiation.
Introduction
Human papillomaviruses (HPVs) are classi®ed as low risk (e.g., HPV-6 and HPV-11) and high risk (e.g., on the basis of association with benign epithelial hyperproliferation or with lesions which can progress to cancer, respectively. Over 90% of cervical carcinomas contain high risk HPV sequences (Bosch et al., 1995) . HPV E6 and E7 are the only HPV genes consistently expressed in HPVpositive cervical carcinoma-derived cell lines and together cooperate to immortalize human keratinocytes. The ability of high risk E6 and E7 to bind to and promote the degradation of the tumor suppressor protein p53 and to inactivate the hypophosphorylated, growth-suppressive form of the retinoblastoma tumor suppressor protein, pRb, respectively, are thought to play a critical function in promoting cellular transformation (reviewed in zur Hausen, 1996) . Mutational analyses of HPV-16 E6 have demonstrated a correlation between p53 targeting activity and cellular immortalization (Nakagawa et al., 1995; Dalal et al., 1996; Stoppler et al., 1996) . A similar correlation has been established for the pRBinactivation and cellular transformation activities of HPV-16 E7 (reviewed in MuÈ nger and Phelps, 1993) . Furthermore, interaction with p53 and pRb is a functional theme shared with other small DNA tumor virus oncoproteins such as SV40 large T antigen and adenovirus E1A/E1B.
Loss of genomic stability is manifested as an increased frequency of cytogenetic aberrations, a proclivity for gene ampli®cation and mutation, and microsatellite instability, and is associated with cellular transformation. In addition to dependence on the presence of intact DNA damage repair systems, it has been hypothesized that maintenance of genomic integrity depends on the capacity of the cell to regulate cell cycle transitions in response to a myriad of external and internal variables. Entry into S-phase or mitosis is regulated by checkpoints, control mechanisms which arrest cell cycle progress in response to an external variable, e.g. the completion of an event in a preceding cell cycle phase or an event such as DNA damage or nutrient deprivation (reviewed in Elledge, 1996) . The compromised nature of these control mechanisms in many cancers is suggested by the numerical and structural chromosomal abnormalities commonly observed in tumor cell populations. Thus, emergence of genomic instability may be a crucial step in the carcinogenic process.
The ability of viral oncoproteins to subvert cell cycle checkpoints may constitute a mechanism by which viral oncoproteins induce genetic instability. It is welldocumented that viral oncoproteins can subvert G1 checkpoints. The p53 tumor suppressor protein regulates G1 checkpoints and is mutated in a wide variety of cancers (reviewed in Levine, 1997) . p53 is also targeted by several small DNA tumor virus oncoproteins. HPV-16 E6 abrogates the G1 arrest response to DNA damage (Kessis et al., 1993; Demers et al., 1994; Hickman et al., 1994) . HPV-16 E7 also disrupts the G1 arrest response to DNA damage as well as to TGF-b treatment and suprabasal quiescence in epithelial cells in organotypic culture .
The ability of DNA tumor virus oncoproteins to interfere with mitotic checkpoints has been less well studied. SV40 large T antigen rapidly decreases ®delity of several mitotic checkpoints in normal human cells and a concomitant increased frequency of cytogenetic aberrations is observed (Chang et al., 1997) . Expression of HPV-16 E6/E7 causes an increase in cytogenetic aberrations in normal human ®broblasts and both HPV-16 E6 and E7 are reported to induce such aberrations prior to immortalization in normal diploid human ®broblasts or keratinocytes (Hashida and Yasumoto, 1991; White et al., 1994) .
To directly address whether, as a possible means of generating genomic instability, HPV-16 E6 or E7 in¯uences mitotic checkpoints, we examined the effects of acute expression of HPV-16 E6 and E7 in normal diploid human lung ®broblasts and primary human foreskin keratinocytes (HFKs). We found HPV-16 E6, but not E7, rapidly alters multiple aspects of G2/M control and abrogates three checkpoints: the response coupling cell cycle progression through the G2/M boundary to a sensor of DNA damage, the checkpoint coupling onset of mitosis to completion of DNA replication, and the mitotic spindle assembly checkpoint. The ability of HPV-16 E6 to compromise mitotic checkpoints correlates with its ability to target p53 for degradation. Expression of a mutant p53 allele produced qualitatively similar eects, but the allele appeared less potent than HPV-16 E6.
Results

Retroviral infections
To study whether HPV oncoproteins can disregulate mitotic checkpoints, we infected normal diploid IMR-90 human lung ®broblasts or primary HFKs with recombinant retroviruses containing HPV-16 E6 or E7 sequences. In some studies, mutants of HPV-16 E6 retaining or lacking the ability to target p53 for degradation were used (Table 1 ). The ability of these retroviruses to produce stable proteins was examined in prior studies (Halbert et al., 1991; Foster et al., 1994) . In the absence of sensitive, speci®c antibodies for HPV-16 E6, we con®rmed the identity and expression of HPV-16 E6 and HPV-16 E6 mutants by analysing steady-state levels of p53 by immunoblotting. HPV-16 E6 and the 118 mutant both markedly reduced p53 levels ( Figure 1a ). In contrast, the HPV-16 E6 YYH and JH26 mutants did not cause reduced steady-state p53 levels ( Figure 1a) . Expression of HPV-16 E7 was analysed by immunoblot analysis (Figure 1b ).
HPV-16 E6 decreases the G2 delay response to ionizing radiation
Most mammalian cell types respond to ionizing radiation by delaying cell cycle progression prior to the G1/S and G2/M boundaries. The G2/M delay response is thought to prevent cells with damaged DNA from entering mitosis and results in a decline in the fraction of mitotic cells after exposure to a DNA damaging agent. To determine whether HPV-16 E6 or E7 compromises the G2 delay response to ionizing radiation, the mitotic index of IMR-90 cells infected with retroviruses containing the HPV-16 E6 or E7 gene was quanti®ed after cells were exposed to 150 rads from a 60 Co source. Within 2 ± 3 h postirradiation, the mitotic index of cells infected with the LXSN control vector or with the HPV-16 E7 retroviral vector fell to less than 10% of the initial mitotic index (Figure 2 ). In contrast, by 2 ± 3 h postirradiation, the mitotic index of cells expressing HPV-16 E6 fell to approximately 40% of the initial mitotic index (Figure 2 ), indicating a de®cient G2 delay response. Cells expressing the low risk HPV-6 E6 protein did not exhibit a G2 delay response dierent from that of cells infected with the LXSN retrovirus (data not shown).
Since the time required for IMR-90 cells to transit from G1 to M phase is greater than the 2 ± 3 h by which we observe maximal G2 delay (Figure 2) , it is unlikely the observed delay re¯ects an eect related to a G1/S block. However, to address the possibility of a G1/S arrest in¯uencing our observations, we Figure 3 ). Since HPV-16 E6 is associated with elevated levels of cdk activity, both with a cdk regulating the transition into mitosis and with a cdk regulating the transition into S-phase, we examined two additional mitotic checkpoints ± one coupling completion of S with entry into M and one coupling exit from M with transition into the subsequent cell cycle (the mitotic spindle assembly checkpoint).
HPV-16 E6 increases sensitivity to chemically-induced premature chromosome condensation (PCC)
Under normal circumstances, mitosis does not commence prior to completion of S-phase. Com- pounds such as okadaic acid and caeine are unable to eciently uncouple S-phase and mitosis in human cells due to engagement of a checkpoint coupling the two cell cycle phases. However, when this checkpoint fails, treatment of cells arrested in S-phase with these compounds yields a highly fragmented mass of condensed chromatin. We examined whether the frequency of caeine-induced S-phase PCC is elevated in normal human ®broblasts expressing HPV oncoproteins. Consistent both with the elevated cdc2-associated kinase activity observed in IMR-90 cells infected with the HPV-16 E6 retroviral vector and with the increased proclivity of these cells to enter mitosis after irradiation, IMR-90 cells expressing HPV-16 E6 displayed an approximately 3 ± 4-fold heightened sensitivity to caeine-induced PCC relative to cells infected with the control vector, LXSN (Figure 4a and b). This eect was not observed in cells expressing HPV-16 E7 ( Figure 4a ). To determine if the`high' or`low risk' status of the HPV from which E6 was derived is related to its ability to in¯uence sensitivity to caeine-induced PCC, IMR-90 cells were infected with retrovirus encoding the HPV-6 E6 gene and examined for sensitivity to caeine-induced S-phase PCC. HPV-6 E6 did not in¯uence sensitivity to caeine-induced S-phase PCC ( Figure 4a ).
One biochemical activity that distinguishes high-risk HPV E6 proteins from low-risk HPV E6 proteins is the capacity to interact with and induce the proteolytic degradation of p53 (Schener et al., 1990) . Since p53 has been implicated in some aspects of the G2/M transition (Agarwal et al., 1995; Katayose et al., 1995; Stewart et al., 1995) , we hypothesized that one means by which HPV-16 E6 decreases mitotic ®delity is via targeting p53. We examined the capacity of mutants of HPV-16 E6 either retaining p53 targeting activity or defective in p53 targeting (Table 1) to in¯uence sensitivity to caeine-induced S-phase PCC. IMR-90 cells expressing HPV-16 E6 mutants (YYH and JH26) defective in p53 targeting behaved similarly to control vector-infected cells with respect to sensitivity to caeine-induced PCC (Figure 4b ). In contrast, cell populations expressing the HPV-16 E6 mutant, 118, retaining p53 targeting activity behaved similarly to wild-type HPV-16 E6 expressing cells with respect to sensitivity to caeineinduced S-phase PCC (Figure 4b ).
To determine whether the ability of HPV-16 E6 to sensitize to S-phase PCC induction extends to the physiological HPV target cell type, we examined the eects of HPV-16 E6 and E7 on this checkpoint in primary HFKs. In multiple experiments, we were unable to induce S-phase PCC in primary HFKs by caeine treatment (data not shown). However, primary HFKs undergo S-phase PCC in response to treatment with the phosphatase inhibitor, okadaic acid ( Figure  4c ). HPV-16 E6 potentiated this sensitivity (Figure 4c ), indicating that it also disregulates checkpoints governing entry into M-phase in HFKs.
HPV-16 E6 disregulates the mitotic spindle assembly checkpoint
The mitotic spindle assembly checkpoint couples proper spindle assembly and chromosome segregation a b c Figure 4 (a) HPV-16 E6 increases sensitivity to caeine-induced S-phase PCC. IMR-90 cells infected with the indicated retroviruses were evaluated for sensitivity to caeine-induced PCC as described in Materials and methods. Error bars represent the sample standard deviation of pooled results of independent experiments. The elevation in PCC in the HPV-16 E6-expressing population is signi®cant at 95% using the standard normal distribution with Bonferoni correction for multiple comparisons. (b) The ability of mutant HPV-16 E6 proteins to target p53 for degradation correlates with sensitivity to caeine-induced S-phase PCC. IMR-90 cells infected with the indicated retroviruses were evaluated for sensitivity to caeine-induced PCC as described in Materials and methods. Error bars represent sample standard deviation of pooled results of 2 ± 4 independent experiments (not all mutants were included in each experiment). Elevations in PCC in populations expressing HPV-16 E6 or the E6 mutant, 118, are signi®cant at 95% using the standard normal distribution with Bonferoni correction for multiple comparisons. (c) Okadaic acidinduced S-phase PCC in HFKs expressing HPV-16 E6. HFK cells expressing the indicated HPV coding sequences were evaluated for sensitivity to okadaic acid-induced PCC as described in Materials and methods. Error bars represent sample standard deviations of pooled results of two experiments. The elevation in PCC in the HPV-16 E6-expressing population is signi®cant at 95% using the standard normal distribution to exit from mitosis. To examine whether this checkpoint is compromised in cells expressing HPV oncoproteins, we assessed the ability of IMR-90 cells expressing HPV-16 E6 or E7 to progress through the cell cycle in the presence of nocodazole, an inhibitor of spindle assembly. The presence of cells which acquire DNA content greater than 4N under such conditions is indicative of at least one additional round of DNA replication occurring in the absence of successful completion of cytokinesis. FACS analysis revealed a heightened tendency of HPV-16 E6-expressing cells to accumulate 8N DNA content 48 h after nocodazole treatment (Figure 5a ). Over ®ve independent experiments, the mean increase of the 8N population in HPV-16 E6-expressing cells relative to control vectorinfected cells was 4.2-fold (standard error, 0.8). In contrast, in four independent experiments, IMR-90 cells expressing HPV-16 E7 exhibited a mean increase in 8N population of 1.6-fold (standard error, 0.6) relative to control vector-infected cells.
To determine if the high or low risk status of the virus of origin of HPV E6 is a determinant of its ability to in¯uence the mitotic spindle assembly checkpoint, IMR-90 cells were infected with retrovirus encoding the HPV-6 E6 gene and examined for an intact spindle assembly checkpoint. HPV-6 E6 was unable to in¯uence the spindle assembly checkpoint (Figure 5a ).
As low-risk HPV E6 proteins are unable to target p53 for degradation (Crook et al., 1991) , we examined the capacity of mutants of HPV-16 E6 defective in p53 targeting (Table 1) to in¯uence the spindle assembly checkpoint. IMR-90 cells expressing HPV-16 E6 mutants defective in p53 targeting (YYH and JH26) behaved similarly to control vector-infected cells with respect to integrity of the spindle assembly checkpoint. However, cell populations expressing an HPV-16 E6 mutant retaining p53 targeting activity (118) exhibited impaired spindle assembly checkpoint function quantitatively resembling that induced by HPV-16 E6 ( Figure  5b) .
To con®rm the HPV-16 E6-induced spindle assembly checkpoint defect, we prepared chromosome spreads from IMR-90 cells infected with the HPV-16 E6 retrovirus and subsequently incubated for 48 h in nocodazole. As chromosomes form`tighter' clusters in nocodazole arrested cells than in colcemid-arrested cells, the chromosome counts represent estimates of the actual chromosome number per cell. The cell population expressing HPV-16 E6 accumulated an approximately 4.5-fold larger subpopulation of tetraploid mitotic cells relative to the cell population infected with control retrovirus (Figure 5c ).
To determine whether HPV-16 E6 retains its potency with respect to the spindle assembly checkpoint in epithelial cells, we examined the eect of HPV-16 E6 on the spindle assembly checkpoint on primary HFKs. Consistent with our ®ndings in IMR-90 cells, expression of HPV-16 E6 in HFKs was associated with a heightened tendency to rereplicate DNA in the presence of nocodazole (Figure 5d ).
Dominant negative p53 alleles partially decrease G2/M checkpoint function
Given the correlative evidence implicating HPV-16 E6-mediated p53 degradation in abrogation of the checkpoints described above, we examined whether p53 function may be necessary for the integrity of these mitotic checkpoints. Another means of interfering with p53 function is through expression of a dominant negative mutant of p53. A LXSN-based retroviral vector (L143) expressing the V143A p53 mutant allele (Baker et al., 1990 ) was used to infect IMR-90 cells. Immunoblot analysis con®rmed that the V143A p53 mutant protein was expressed at high levels in these cells (Figure 6a ). To con®rm L143 activity, we examined DNA damage-induced p21 expression in IMR-90 cells infected with retrovirus encoding the V143A p53 mutant allele. An attenuated response was observed in cells infected with the L143 retrovirus relative to cells infected with control retroviral vector (Figure 6b) , suggesting that the L143 retroviral construct is functional.
To determine whether expression of the V143A p53 allele compromises the G2 delay response to ionizing radiation, the mitotic index of IMR-90 cells infected with the L143 retrovirus was quanti®ed after cells were exposed to 150 rads from a 60 Co source. Within 2 ± 3 h post-radiation, the mitotic index of cells infected with the LXSN control vector fell to less than 10% of the initial mitotic index (Figure 6c ). In contrast, at 2 to 3 h post-irradiation, cells expressing the V143A p53 mutant allele retained approximately 20% of the initial mitotic index (Figure 6c ). Although substantial, this eect was less pronounced than the retention of approximately 50% of initial mitotic index observed with HPV-16 E6.
To determine whether the V143A p53 mutant allele exerted an eect on other G2/M checkpoints, we examined the frequency of caeine-induced S-phase PCC in normal human ®broblasts expressing the p53 mutant protein. IMR-90 cells expressing the V143A p53 mutant allele displayed a modest but statistically signi®cant increase in sensitivity to caeine-induced PCC relative to cells infected with the control vector, LXSN (Figure 6d ). This eect was less pronounced than that observed with HPV-16 E6 (Figure 6d) .
We also examined whether the mitotic spindle assembly checkpoint is compromised in cells expressing the V143A p53 mutant allele by assessing the ability of IMR-90 cells expressing the V143A p53 mutant allele to progress through the cell cycle in the presence of nocodazole. FACS analysis revealed that a heightened percentage of V143A p53-expressing cells accumulated 8N DNA content 48 h after nocodazole treatment (Figure 6e) . Strikingly, the intermediate eect of the V143A allele on the G1/S and mitotic checkpoints examined was accompanied by an intermediate eect on mitotic cyclin/cdk complex activities (Figure 3) . To exclude the possibility that the results observed with the V143A p53 mutant allele are allele speci®c, we examined whether an additional dominant negative p53 allele was able to in¯uence mitotic control. The DD p53 miniprotein (Gottlieb et al., 1994) comprises the last 89 residues of murine p53, including the p53 oligomerization domain, and is able to eciently antagonize p53 activity in multiple assays (Shaulian et al., 1992; Gottlieb et al., 1994) . We used the retroviral vector, LXSNp53DD, encoding the DD miniprotein to infect IMR-90 cells and examined the in¯uence of the DD miniprotein on mitotic control. Results obtained with respect to cdc2-associated histone H1 kinase activity, the G2 delay response to ionizing radiation, and sensitivity to caeine-induced S-phase PCC (data not shown) were similar to those observed with the single amino acid p53 mutant, V143A, suggesting that these results are not allele speci®c. Together, our results suggest that p53 may be involved in regulation of the three mitotic checkpoints described, possibly via regulation of mitotic cyclin/cdk activity. CIP1/WAF1 expression. Two independent populations of IMR-90 cells infected with L143 (V143A-1 and V143A-2) were exposed to 1000 rads from a 60 Co source and compared to a population infected with LXSN retrovirus. Extracts were prepared 4.5 h post-irradiation and immunoblot analysis conducted with a p21 CIP1/WAF1 -speci®c antibody as described in Materials and methods. (c) Eect of the V143A p53 mutant allele on DNA damage-induced G2 delay. IMR-90 cells infected with the indicated retroviruses were exposed to 150 rads from a 60 Co source. At the indicated times post-exposure, cells were ®xed and mitotic cells were identi®ed by Hoechst 33258 staining and uorescence microscopy. (d) Eect of the V143A p53 mutant allele on sensitivity to caeine-induced S-phase PCC. IMR-90 cells infected with the indicated retroviruses were evaluated for sensitivity to caeine-induced PCC as described in Materials and methods. Error bars represent the 95% con®dence interval using the binomial distribution. Elevations in PCC in HPV-16 E6-and V143A-expressing populations are signi®cant at 95% using the standard normal distribution with Bonferoni correction for multiple comparisons. Data from pooled results of three additional independent L143 infections con®rmed the ability of V143A to increase sensitivity to caeine-induced PCC (statistical signi®cance was evaluated at 95% using the binomial distribution; data not shown).
(e) Eect of the V143A p53 mutant allele on integrity of the mitotic spindle assembly checkpoint. Analysis was the same as described in Figure 
HPV-16 E6 disrupts multiple mitotic checkpoints
We have demonstrated that the HPV-16 E6 oncoprotein compromises three mitotic checkpoints: the G2 delay response to irradiation, S/M phase coupling (assessed by quantifying chemically-induced S-phase PCC), and the spindle assembly checkpoint. These same checkpoints are also targeted by SV40 large T antigen, another DNA tumor virus oncoprotein capable of immortalizing human cells, suggesting their potential importance in tumor virus-mediated oncogenesis (Chang et al., 1997) . Delay of cell cycle progression in G2 following DNA damage is thought to allow time to repair damaged DNA prior to mitosis. Consistent with this, cells lacking the G2 delay response or cells treated with agents which abrogate the G2 delay response exhibit hypersensitivity to DNA damage (Lau et al., 1982; Weinert et al., 1988) . We ®nd that HPV-16 E6-expressing normal human ®broblasts retain only a partial capacity to arrest cell cycle progression at G2/ M in response to DNA damage (Figure 2 ). The partial decline in mitotic index observed in these cells may re¯ect the presence of low levels of p53 still present in HPV-16 E6-expressing cells or the presence of multiple DNA damage recognition pathways, perhaps recognizing distinct forms of DNA damage, of which E6 inactivates only a subset. The conservation of this viral function between HPV and SV40 supports its functional importance Chang et al., 1997) . Interestingly, expression of HPV-16 E6 in human diploid ®broblasts was reported to cause increased radioresistance, although this eect appeared marginal at the 150 rad dose used in the present study (Tsang et al., 1995) .
In contrast to our observations, Paules et al. reported that acute expression of HPV-16 E6 in normal human foreskin ®broblasts does not perturb the G2 delay response to DNA damage; a defective response was acquired only after 10 ± 11 passages . The disparity between our observations and those of Paules et al. may be attributable to the source of the ®broblasts used in each study or to our use of a substantially lower ionizing radiation dose. It is also possible that a dierential maximum extent of delay or dierential recovery from delay went undetected in the study of Paules et al. since mitotic indices were quanti®ed at only one time point while we examined the mitotic index at multiple time points . An intact G2 delay response was reported in MCF-7 breast tumor cells containing HPV-16 E6; however, this response is readily abrogated by UCN-01 (a staurosporine analog) treatment in cells containing E6, but not in the parental cell population (Wang et al., 1996) , suggesting E6 increases susceptibility to chemical disruption of G2 checkpoint control. Furthermore, human tumor cells expressing HPV-16 E6 exhibit heightened sensitivity to methylxanthine-induced override of radiation-induced G2 delay (Russell et al., 1995 (Russell et al., , 1996 .
In normal human cells, initiation of mitosis is tightly coupled to completion of S-phase. The 3 ± 4-fold sensitization to chemically-induced S-phase PCC associated with HPV-16 E6 expression yields a PCC frequency approaching 1%, a number signi®cantly greater than that observed in normal cells (Figure 4) . It is possible that relaxation of the coupling of S-phase completion to initiation of mitosis by HPV-16 E6 establishes a more permissive environment for accumulation of DNA damage, allowing progression towards cancer.
Tetraploidy is frequently observed in human cervical cancer and is thought to be an early step in tumor progression (Steinbeck et al., 1995; Heselmeyer et al., 1996) . While the cause of tetraploidy in cervical cancer is unknown, most cervical cancers are HPV positive. Our ®nding of decreased spindle assembly checkpoint activity in cells expressing HPV-16 E6 suggests E6 may be one component involved in allowing the HPVpositive cell to progress to polyploidy. Similar results to ours were obtained in a recently published study (Di Leonardo et al., 1997) . Interestingly, in this study, an eect of HPV-16 E7 on mitotic spindle assembly checkpoint function was detected after extended exposure to nocodazole, suggesting HPV-16 E7 does disregulate the mitotic spindle assembly checkpoint, but with kinetics distinct from HPV-16 E6 (Di Leonardo et al., 1997) . In our system, the eects we have observed with HPV-16 E7 have been consistently less than those observed with HPV-16 E6. Additional experiments will be required to address these differences.
Disregulated cdc2 activity may contribute to compromised mitotic checkpoints
Altered regulation or expression of cdks may contribute to genomic instability. Our observation of elevated cdc2-associated H1 kinase activity in preimmortal human cell populations infected with recombinant HPV-16 E6 retrovirus (Figure 3 ) parallels that observed for SV40 large T antigen, suggesting it may be a common strategy by which small DNA tumor virus oncoproteins disregulate G2/M control (Chang et al., 1997) . Elevated activities of mitotic regulatory proteins were previously reported in HPVimmortalized keratinocytes (Steinmann et al., 1994) . Here we show that this alteration in cdc2-associated kinase activity is caused by HPV-16 E6 and occurs prior to immortalization. Therefore, this alteration potentially plays a causal role in generating genetic instability and contributing to the immortalization process. The eect of HPV-16 E6 on kinase activities is not global in nature as other cell cycle-associated kinase activities are not altered by HPV-16 E6 expression (Gu and Matlashewski, 1995) . Association of mitotic cyclins with cdc2 is not altered in HPV-16 E6-expressing primary human ®broblasts (Xiong et al., 1996) , indicating that HPV-16 E6 in¯uences cdc2-associated histone H1 kinase activity at a posttranslational step distinct from cdk-cyclin complex formation. Since the level of cdc2/cyclin B complexassociated p21 is reduced in HPV-16 E6-expressing cells (Xiong et al., 1996) , it is possible that the observed elevation in cdc2 activity is attributable to an altered amount of associated p21.
Possibly, HPV-16 E6 alters mitotic checkpoint ®delity through its eect on cdc2 activity. Timing of cdc2/cyclin B complex formation and extent of cyclin B synthesis during S-phase arrest both correlate with sensitivity to caeine-induced PCC (Steinmann et al., 1991; Tam et al., 1995) . A probable regulatory component of PCC, the small nuclear G protein, Ran, regulates cdc2/cyclin B complex activity in vitro (Clarke et al., 1995) . Furthermore, in many mammalian systems, decreased cdc2 activity and persistent cdc2 hyperphosphorylation accompany radiation-or chemically-induced mitotic delay, suggesting that checkpoints dependent on DNA status act through a pathway which regulates cdc2 activity (reviewed in Maity et al., 1994) . One recent study clearly supports this hypothesis: expression in HeLa cells of a mutant form of cdc2 lacking the inhibitory T14 and Y15 phosphorylation sites led to elevated PCC of S-phase cells and an attenuated G2 delay response to ionizing radiation (Jin et al., 1996) . Hence, the elevated cdc2 Bassociated kinase activity observed in cell populations containing HPV-16 E6 or SV40 T may contribute to the increased sensitivity of these cells to PCC induction and to the decreased sensitivity of these cells to irradiation.
The relationship of cdc2 activity to spindle assembly checkpoint integrity is less clear. One plausible scenario is that the elevated cdc2 activity present in cells containing HPV-16 E6 leads to a prolonged residence in mitosis; coupled with elevated cdk2 activity ( Figure  2 ), this may lead to an increased tendency to enter Sphase prior to successfully exiting M-phase.
HPV-16 E6 disruption of mitotic checkpoints may require p53 inactivation
In contrast to the potency of high risk (HPV-16) E6 in compromising mitotic checkpoints, we found that low risk (HPV-6) E6 was unable to markedly compromise mitotic checkpoints (Figures 4a and 5a and data not shown). Since high and low risk HPV E6 proteins dier in their ability to target p53 for degradation and in their ability to promote oncogenesis, these results suggest compromise of mitotic checkpoints by HPV E6 may require its ability to target p53 for proteolysis. Furthermore, these results raise the possibility that disruption of mitotic checkpoints may be required for HPV E6 to eciently promote oncogenesis.
We examined the ability of mutant HPV-16 E6 proteins with diminished p53 targeting activity to in¯uence the spindle assembly checkpoint and sensitivity to caeine-induced PCC. The clear correlation between retention of p53 targeting activity and capacity to abrogate mitotic checkpoints (Figures 4b and 5b) , coupled with the observed disparity between low risk (HPV-6) E6 and high risk (HPV-16) E6 in abrogating mitotic checkpoint ®delity, suggests that the p53-targeting capacity of HPV E6 is required for subversion of mitotic checkpoint control.
A number of studies suggest p53 is able to regulate the G2/M transition. In murine cells, p53 is clearly involved in spindle assembly checkpoint control (Cross et al., 1995) . Moreover, the spindle assembly checkpoint is subverted by two viral oncoproteins, SV40 T antigen and HPV-16 E6, which inactivate p53 ( Figure  5 ) (Chang et al., 1997) . Manipulation of p53 levels using a temperature-sensitive allele, an tetracyclineregulated promoter construct, or an adenoviral vector demonstrated that elevated levels of p53 induce cell cycle arrest at both the G1/S and G2/M boundaries (Agarwal et al., 1995; Katayose et al., 1995; Stewart et al., 1995) . Consistent with these studies, p53 in¯uences G2 arrest in response to g-irradiation (Aloni-Grinstein et al., 1995) and the p53 status of murine and rat ®broblasts is a determinant of sensitivity to caeineinduced override of the G2 delay response to irradiation (Powell et al., 1995) . Furthermore, given the ability of HPV-16 E6 and SV40 T antigen, but not HPV-16 E7, to disrupt the G2 delay response (Figure  2 ), p53 emerges as a possible candidate controlling the G2/M checkpoint response to DNA damage.
To investigate whether direct alteration of p53 activity would produce eects similar to those produced by HPV-16 E6, we introduced the V143A p53 mutant allele into IMR-90 cells. This allele acts in a dominant negative fashion, at least with respect to the transactivation function of p53 (Kern et al., 1992) . While this allele reduced induction of p21 CIP1/WAF1 expression in response to high dose irradiation (Figure 6b ), it yielded an intermediate eect with respect to the G2/M checkpoints examined (Figure 6c, d, e) relative to that observed with HPV-16 E6 ( Figures  2, 4 , and 5). Possibly, the reduced potency of the V143A p53 mutant relative to HPV-16 E6 observed in each assay is attributable to the allele having only a partial dominant negative activity and other dominant negative p53 mutants would produce a more pronounced eect. However, examination of a second dominant negative p53 allele, the p53 DD miniprotein (Gottlieb et al., 1994) , yielded similar results with respect to the G2 delay response to ionizing radiation, caeine-induced S-phase PCC, and cdc2-associated H1 kinase activity of asynchronously growing cells (data not shown). Thus, it remains possible that HPV-16 E6 acts in part through an, as yet unidenti®ed, entity distinct from p53 to decrease the vigilance of mitotic checkpoints.
Our data suggest that, associated with the ability of HPV E6 to target p53 for degradation and to promote oncogenesis, is an ability to disrupt mitotic checkpoints. The disruption of these checkpoints may be a primary means by which the high risk HPV is able to induce genomic instability, bypassing such safeguards as the DNA damage response and the spindle checkpoint, and promote immortalization. Given the probable role of p53 in mitotic checkpoint control, disruption of mitotic checkpoints may be a hallmark of many cancers.
Materials and methods
Cell culture
IMR-90 normal human lung ®broblasts and the PA317 and PG13 retroviral packaging cell lines were grown at 378C with 5% CO 2 in Dulbecco's Minimal Essential Medium supplemented with 10% calf serum (Hyclone) and 3.2 mM glutamine. Primary human foreskin keratinocytes (HFKs) were derived from neonatal foreskins according to standard protocols. HFKs were grown in Keratinocyte-SFM supplemented with bovine pituitary extract and EGF (Gibco) at 378C in 7% CO 2 . HFKs and IMR-90 cells were used at low passage and were regularly split prior to con¯uence.
Retroviral infection
PA317 or PG13 packaging cells transfected with the control vector, LXSN, or with LXSN-based vectors containing HPV type 6 or 16 sequences (Halbert et al., 1991; were kindly provided by D Galloway (Fred Hutchinson Cancer Center, Seattle, WA). The LXSNderived vector containing the p53 coding sequence with a V143A mutation (referred to as L143 hereafter) was kindly provided by R Pomerantz (Thomas Jeerson University, Philadelphia, PA); PA317 packaging cells expressing the LXSN-based retroviral construct were prepared as described (Miller and Rosman, 1989) . Supernatant was harvested from packaging cells and IMR-90 cells were infected as previously described (Miller and Rosman, 1989) . HFKs were infected in an identical fashion except that after incubation with retrovirus for 2 h, media was removed and replaced with fresh growth medium containing supplements. All retroviruses were prepared at high titer. Infected cell populations eectively represent a pooled minimum of 6610 4 clones. Cells exposed to retrovirus were selected in 5300 (IMR-90) or 100 (HFK) mg/ml G418 for at least 6 (IMR-90) or 4 (HFK) days prior to use. 5 cells/100 ml and frozen at 7808C. Directly prior to FACS analysis, cells were thawed, washed in phosphate-buered saline, 0.5 mM EDTA, 0.5% bovine serum albumin, and incubated in 150 ml 100 mg/ml propidium iodide, 40 mg/ml RNase, 0.5 mM EDTA, 0.05% Triton X-100 for 20 min at room temperature. 40 ml 2 M HCl was then added and, after 30 min, 150 ml 1 M Tris base was added and the cells were placed on ice. Data were collected using a Becton-Dickinson FACScan. Typically, at least 10 000 events were counted per sample; debris and cell aggregates were removed during computer analysis by gating. Data were analysed with CellQuest (Becton Dickinson) or WinMDI (J Trotter, Scripps Research Institute) software.
Premature chromosome condensation (PCC)
Approximately 1.9610 5 (IMR-90) or 2.5610 5 (HFK) cells were plated per 25 cm 2¯a sk. For caeine treatment, after 2 days cells were exposed to 2.5 mM hydroxyurea for 7 ± 8 h. Media was then adjusted to 5 mM caeine, 100 ng/ml nocodazole and 2 mM hydroxyurea and cells were incubated for 8 h. For okadaic acid treatment, after 2 days cells were exposed to 2.5 mM hydroxyurea for 16 h; media was then adjusted to 0.67 nM okadaic acid and the cells were incubated for 3 h. Cells were prepared and chromosomes stained as described. Fluorescence microscopy was used to identify cells undergoing S-phase PCC. Five thousand cells were typically counted per sample.
Chromosome analysis
Cells were trypsinized and resuspended in 75 mM KCl at room temperature for 13 min 45 s (IMR-90 cells) or 8 min 30 s (HFKs). After centrifugation and resuspension in approximately 200 ml 75 mM KCl, 3 : 1 (v : v) methanol : acetic acid was added dropwise to a volume of approximately 10 ml. After at least 10 min, cells were centrifuged and resuspended in approximately 300 ml 3 : 1 (v : v) methanol : acetic acid, and dropped onto glass slides.
Slides were stained for 7 min with 1 mg/ml bisbenzimide (Hoechst 33258, Sigma) in 0.1% low-fat milk (Carnation) dissolved in water; slides were rinsed in water. Chromosome counts were conducted using¯uorescence microscopy.
Mitotic delay
Approximately 8610 4 cells were plated per 35 mm dish; 2 days later, cells were exposed to 150 rads of ionizing radiation from a 60 Co source and, at indicated times postexposure, ®xed by exposure to methanol vapor for 10 min followed by immersion in methanol for at least 10 min. After staining with bisbenzimide as described above, the mitotic index was quanti®ed by¯uorescence microscopy. Approximately 1500 cells were counted for each sample.
Histone H1 kinase assay
Asynchronous IMR-90 cells were lysed in buer A (36 mM HEPES, pH 7.5, 225 mM NaCl, 13.5 mM MgCl 2 0.9% Triton X-100, 4.5 mM NaF, 4.5 mM b-glycerophosphate, 1.8 mM EGTA, 1.8 mM EDTA, 10 mg/ml aprotinin, 10 mg/ ml leupeptin, 10 mg/ml pepstatin A, 1 mM Na 3 VO 4 , 0.5 mM PMSF), passed through a 25 gauge needle ten times, and incubated on ice for 30 min. The protein concentration of the sample was assayed by the bicinchoninic acid assay (Pierce) or Bradford assay (Biorad). A sample corresponding to 50 mg of protein was incubated with the appropriate antibody at a 1 : 100 dilution for 1 h at 48C and subsequently with protein A-Sepharose for 1 h at 48C. Antibodies used were anti-p34 cdc2 , anti-cyclin A and anticyclin B (Oshima et al., 1993) , and anti-cdk2 (Meikrantz et al., 1994) . Protein A-Sepharose beads were separated by centrifugation, washed twice with lysis buer and three times with kinase buer (20 mM HEPES-NaOH, pH 7.5, 15 mM EGTA, 20 mM MgCl 2 ) and resuspended in kinase buer containing 0.125 mCi/ml g-32 P-ATP (appr. 6000 Ci/ mmol) and 0.5 mg/ml histone H1. After incubating 20 min at 308C, reactions were stopped by addition of one volume of 26SDS lysis buer (Laemmli, 1970) and boiling for 5 min. A 20 ml aliquot of each sample was analysed by SDS ± PAGE on a 12% gel. The gel was ®xed in 25% trichloroacetic acid, dried, and exposed to Kodak X-OMAT ®lm. Bands were quanti®ed by analysis with a BioRad Molecular Imager phosphoimager and Molecular Analyst software.
Immunoblot analysis
Cells were lysed in buer B (36 mM HEPES, 225 mM NaCl, 13.5 mM MgCl 2 , 0.9% Triton X-100, 4.5 mM NaF, 4.5 mM bglycerophosphate, 1.8 mM EGTA, 1.8 mM EDTA, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 10 mg/ml pepstatin A, 1 mM Na 3 VO 4 , 0.5 mM PMSF), passed through a 25 gauge needle ten times, and incubated on ice for 30 min. Samples with equal protein content (approximately 100 mg) were analysed by SDS ± PAGE on a 12% gel and transferred to a PVDF membrane (Immobilon-P, Millipore). After blocking nonspeci®c binding sites by incubation in 5% Carnation nonfat dry milk (in 10 mM TrisHCl, pH 7.5, 2.5 mM EDTA, 50 mM NaCl, 0.1% Tween-20) the membrane was hybridized with primary antibody, washed, hybridized with horseradish peroxidase-conjugated sheep anti-mouse antibody (Amersham), and analysed by enhanced chemiluminescence (Amersham). Primary antibodies anti-p53 (DO7), anti-p21 (C-19), and anti-E7 (Jones and Munger, 1997) were purchased from Santa Cruz Biochemicals.
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